id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2015-E-3158-0006,FDA,FDA-2015-E-3158,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2017-09-21T04:00:00Z,2017,9,2017-09-21T04:00:00Z,,2017-09-21T13:08:54Z,,0,0,0900006482b696eb
FDA-2015-E-3158-0005,FDA,FDA-2015-E-3158,Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2016-12-13T05:00:00Z,2016,12,2016-12-13T05:00:00Z,,2016-12-13T16:43:40Z,,0,0,0900006482401460
FDA-2015-E-3158-0004,FDA,FDA-2015-E-3158,Determination of Regulatory Review Period for Purposes of Patent Extension; TRUMENBA,Notice,Determinations,2016-12-02T05:00:00Z,2016,12,2016-12-02T05:00:00Z,2017-06-01T03:59:59Z,2016-12-02T17:14:07Z,2016-28916,0,0,09000064823da076
FDA-2015-E-3158-0003,FDA,FDA-2015-E-3158,Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2015-10-20T04:00:00Z,2015,10,2015-10-20T04:00:00Z,,2015-10-20T15:45:32Z,,0,0,0900006481cd58d0
FDA-2015-E-3158-0001,FDA,FDA-2015-E-3158,Patent Extension Application from Pfizer Inc. (on behalf of Wyeth Holding LLC),Other,Application,2015-08-27T04:00:00Z,2015,8,2015-08-27T04:00:00Z,,2015-08-27T16:43:37Z,,0,0,0900006481c3e667
FDA-2015-E-3158-0002,FDA,FDA-2015-E-3158,Letter from U.S. Patent and Trademark Office,Other,Letter(s),2015-08-27T04:00:00Z,2015,8,2015-08-27T04:00:00Z,,2015-08-27T16:47:49Z,,0,0,0900006481c3e665